Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor

被引:14
|
作者
Bertini, Simone [1 ]
Chicca, Andrea [2 ]
Gado, Francesca [1 ]
Arena, Chiara [1 ]
Nieri, Daniela [2 ]
Digiacomo, Maria [1 ]
Saccomanni, Giuseppe [1 ]
Zhao, Pingwei [3 ]
Abood, Mary E. [3 ]
Macchia, Marco [1 ]
Gertsch, Jurg [2 ]
Manera, Clementina [1 ]
机构
[1] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy
[2] Univ Bern, NCCR TransCure, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland
[3] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA
关键词
Allosteric modulator; CB1; receptor; Endocannabinoid system; MAPK/ERK signaling pathway; Serum response element; ENDOCANNABINOID SYSTEM; HUMAN HEALTH; PHARMACOLOGY; STRATEGIES; AGONISTS; PAIN;
D O I
10.1016/j.bmc.2017.10.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this work, we explored the molecular framework of the known CB1R allosteric modulator PSNCBAM-1 with the aim to generate new bioactive analogs and to deepen the structure-activity relationships of this type of compounds. In particular, the introduction of a NH group between the pyridine ring and the phenyl nucleus generated the amino-phenyl-urea derivative SN15b that behaved as a positive allosteric modulator (PAM), increasing the CB1R binding affinity of the orthosteric ligand CP55,940. The functional activity was evaluated using serum response element (SRE) assay, which assesses the CB1R-dependent activation of the MAPK/ERK signaling pathway. SN15b and the biphenyl-urea analog SC4a significantly inhibited the response produced by CP55,940 in the low mu M range, thus behaving as negative allosteric modulators (NAMs). The new derivatives presented here provide further insights about the modulation of CB1R binding and functional activity by allosteric ligands. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6427 / 6434
页数:8
相关论文
共 50 条
  • [31] A novel allosteric modulator of the cannabinoid CB1 receptor ameliorates hyperdopaminergia endophenotypes in rodent models
    Catharine A. Mielnik
    Kim S. Sugamori
    David B. Finlay
    Hayley H. A. Thorpe
    Matthieu Schapira
    Nirunthan Sivananthan
    Chun Kit Li
    Vincent M. Lam
    Sean Harrington
    Mostafa H. Abdelrahman
    Laurent A. Trembleau
    W. McIntyre Burnham
    Jibran Y. Khokhar
    Ali Salahpour
    Amy J. Ramsey
    Michelle Glass
    Iain R. Greig
    Ruth A. Ross
    Neuropsychopharmacology, 2021, 46 : 413 - 422
  • [32] Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation
    Thapa, Dinesh
    Cairns, Elizabeth A.
    Szczesniak, Anna-Maria
    Kulkarni, Pushkar M.
    Straiker, Alex J.
    Thakur, Ganesh A.
    Kelly, Melanie E. M.
    MOLECULES, 2020, 25 (02):
  • [33] Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure-Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1)
    German, Nadezhda
    Decker, Ann M.
    Gilmour, Brian P.
    Gay, Elaine A.
    Wiley, Jenny L.
    Thomas, Brian F.
    Zhang, Yanan
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (18) : 7758 - 7769
  • [34] Cannabinoid CB1 Receptor Antagonists
    Thomas, Brian F.
    DRUG DEVELOPMENT RESEARCH, 2009, 70 (08) : 525 - 526
  • [35] The CB1 cannabinoid receptor in the brain
    Howlett, AC
    NEUROBIOLOGY OF DISEASE, 1998, 5 (06) : 405 - 416
  • [36] CB1 cannabinoid receptor ligands
    Thakur, GA
    Nikas, SP
    Makriyannis, A
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (07) : 631 - 640
  • [37] CB1 cannabinoid receptor antagonists
    Barth, F
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 103 - 118
  • [38] Synthesis and biological evaluation of indole-2-carboxamides bearing photoactivatable functionalities as novel allosteric modulators for the cannabinoid CB1 receptor
    Qiao, Chang-Jiang
    Ali, Hamed I.
    Ahn, Kwang H.
    Kolluru, Srikanth
    Kendall, Debra A.
    Lu, Dai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 121 : 517 - 529
  • [39] The Cannabinoid CB1 Receptor in Schizophrenia
    Borgan, Faith
    Kokkinou, Michelle
    Howes, Oliver
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2021, 6 (06) : 646 - 659
  • [40] Structural dynamics and energetics underlying allosteric inactivation of the cannabinoid receptor CB1
    Fay, Jonathan F.
    Farrens, David L.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (27) : 8469 - 8474